IPCALAB.NS WACC - Weighted Average Cost of Capital

The WACC of IPCA Laboratories Ltd (IPCALAB.NS) is 13.6%.

The Cost of Equity of IPCA Laboratories Ltd (IPCALAB.NS) is 13.90%.

The Cost of Debt of IPCA Laboratories Ltd (IPCALAB.NS) is 6.10%.

	Range	Selected
Cost of equity	12.90% - 14.90%	13.90%
Tax rate	19.40% - 25.70%	22.55%
Cost of debt	4.60% - 7.60%	6.10%
WACC	12.6% - 14.6%	13.6%

WACC

IPCALAB.NS WACC calculation

Category	Low	High

Long-term bond rate	6.9%	7.4%
Equity market risk premium	8.3%	9.3%
Adjusted beta	0.73	0.76

Additional risk adjustments	0.0%	0.5%
Cost of equity	12.90%	14.90%

Tax rate	19.40%	25.70%
Debt/Equity ratio	0.04	0.04
Cost of debt	4.60%	7.60%

After-tax WACC	12.6%	14.6%


Selected WACC	13.6%

IPCALAB.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for IPCALAB.NS:

cost_of_equity (13.90%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.73) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.